Literature DB >> 19771249

Mouse orthotopic lung cancer model induced by PC14PE6.

Zheng Yun Cui1, Jin Seok Ahn, Jee Yun Lee, Won Seog Kim, Ho Yeong Lim, Hyun Jung Jeon, Soo Won Suh, Jin Hoon Kim, Won Ho Kong, Ji Min Kang, Do Hyun Nam, Keunchil Park.   

Abstract

PURPOSE: This study was undertaken to investigate in detail the xenograft mouse orthotopic lung cancer model induced by PC14PE6 adenocarcinoma cells.
MATERIALS AND METHODS: Three cell doses (0.5x10(6); 1x10(6); 2x10(6)) of PC14PE6 cells were injected into the lungs of male BALB/c nude mice by the intrathoracic injection method. The lung and other organs, including brain, liver, spleen, kidney, muscle, adrenal gland, and lymph node on knee, were removed and stained with H/E to detect the presence of tumor cells.
RESULTS: The reliable tumorigenicity time in the PC14PE6 adenocarcinoma cell-inoculated BALB/c nude mouse was 10 days after intrathoracic injection. The average life span of the three groups after inoculation was 14 days in the 2x10(6) cells inoculum group; 25 days in the 1x10(6) cells inoculum group; and 32 days in the 0.5x10(6) cells inoculum group. The PC14PE6 adenocarcinoma cells induced orthotopic lung cancer limited within the thorax.
CONCLUSIONS: This orthotopic lung cancer model is an efficient cancer model with easy inoculation methods, rapid and high tumorigenicity, and simple monitoring methods for metastasis.

Entities:  

Keywords:  Animal model; Lung cancer; Orthotopic; PC14PE6

Year:  2006        PMID: 19771249      PMCID: PMC2741646          DOI: 10.4143/crt.2006.38.4.234

Source DB:  PubMed          Journal:  Cancer Res Treat        ISSN: 1598-2998            Impact factor:   4.679


  18 in total

1.  Orthotopic growth and metastasis of human prostate carcinoma in nude mice after transplantation of histologically intact tissue.

Authors:  X Fu; H Herrera; R M Hoffman
Journal:  Int J Cancer       Date:  1992-12-02       Impact factor: 7.396

2.  Metastasis results from preexisting variant cells within a malignant tumor.

Authors:  I J Fidler; M L Kripke
Journal:  Science       Date:  1977-08-26       Impact factor: 47.728

3.  The distribution of secondary growths in cancer of the breast. 1889.

Authors:  S Paget
Journal:  Cancer Metastasis Rev       Date:  1989-08       Impact factor: 9.264

Review 4.  Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic.

Authors:  R M Hoffman
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

5.  A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens.

Authors:  X Fu; F Guadagni; R M Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

6.  Novel intrapulmonary model for orthotopic propagation of human lung cancers in athymic nude mice.

Authors:  T L McLemore; M C Liu; P C Blacker; M Gregg; M C Alley; B J Abbott; R H Shoemaker; M E Bohlman; C C Litterst; W C Hubbard
Journal:  Cancer Res       Date:  1987-10-01       Impact factor: 12.701

Review 7.  Metastatic models of human cancer xenografted in the nude mouse: the importance of orthotopic transplantation.

Authors:  T Kubota
Journal:  J Cell Biochem       Date:  1994-09       Impact factor: 4.429

8.  Site-specific chemosensitivity of human small-cell lung carcinoma growing orthotopically compared to subcutaneously in SCID mice: the importance of orthotopic models to obtain relevant drug evaluation data.

Authors:  T H Kuo; T Kubota; M Watanabe; T Furukawa; S Kase; H Tanino; Y Saikawa; K Ishibiki; M Kitajima; R M Hoffman
Journal:  Anticancer Res       Date:  1993 May-Jun       Impact factor: 2.480

9.  Orthotopic and ectopic organ environments differentially influence the sensitivity of murine colon carcinoma cells to doxorubicin and 5-fluorouracil.

Authors:  C Wilmanns; D Fan; C A O'Brian; C D Bucana; I J Fidler
Journal:  Int J Cancer       Date:  1992-08-19       Impact factor: 7.396

10.  A patient-like metastasizing model of human lung adenocarcinoma constructed via thoracotomy in nude mice.

Authors:  X Wang; X Fu; R M Hoffman
Journal:  Anticancer Res       Date:  1992 Sep-Oct       Impact factor: 2.480

View more
  5 in total

1.  A novel bioluminescence orthotopic mouse model for advanced lung cancer.

Authors:  Bo Li; Artour Torossian; Wenyan Li; Stephen Schleicher; Kathy Niu; Nicholas J Giacalone; Sung June Kim; Heidi Chen; Adriana Gonzalez; Luigi Moretti; Bo Lu
Journal:  Radiat Res       Date:  2011-06-10       Impact factor: 2.841

2.  LPP inhibits collective cell migration during lung cancer dissemination.

Authors:  S Kuriyama; M Yoshida; S Yano; N Aiba; T Kohno; Y Minamiya; A Goto; M Tanaka
Journal:  Oncogene       Date:  2015-06-01       Impact factor: 9.867

3.  Modest anti-cancer activity of a bile acid acylated heparin derivative in a PC14PE6 induced orthotopic lung cancer model.

Authors:  Zheng Yun Cui; Min Jae Park; Jeeyun Lee; Jin Seok Ahn; Myung Ju Ahn; Soo Won Seo; Jin Woo Park; Youngro Byun; Keunchil Park
Journal:  Cancer Res Treat       Date:  2009-06-30       Impact factor: 4.679

4.  Establishment of an orthotopic lung cancer model in nude mice and its evaluation by spiral CT.

Authors:  Xiang Liu; Jun Liu; Yubao Guan; Huiling Li; Liyan Huang; Hailing Tang; Jianxing He
Journal:  J Thorac Dis       Date:  2012-04-01       Impact factor: 2.895

5.  Orthotopic model of lung cancer: isolation of bone micro-metastases after tumor escape from Osimertinib treatment.

Authors:  Thierry Guillaudeux; Rémy Pedeux; Ulrich Jarry; Mégane Bostoën; Raphaël Pineau; Laura Chaillot; Valentine Mennessier; Pierre Montagne; Emilie Motte; Marjorie Gournay; Arnaud Le Goff
Journal:  BMC Cancer       Date:  2021-05-10       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.